Korean J Gastroenterol.
2016 May;67(5):233-237. 10.4166/kjg.2016.67.5.233.
Fecal Calprotectin in Inflammatory Bowel Disease
- Affiliations
-
- 1Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Korea. leejun@chosun.ac.kr
- KMID: 2164329
- DOI: http://doi.org/10.4166/kjg.2016.67.5.233
Abstract
- Inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis comprise conditions characterized by chronic, relapsing immune activation and inflammation within the gastrointestinal tract. Objective estimation of intestinal inflammation is the mainstay in the diagnosis and observation of IBD, but is primarily dependent on expensive and invasive procedures such as endoscopy. Therefore, a simple, noninvasive, inexpensive, and accurate test would be extremely important in clinical practice. Fecal calprotectin is a calcium-containing protein released into the lumen that is excreted in feces during acute and chronic inflammation. It is well-researched, noninvasive, and has high sensitivity and specificity for identification of inflammation in IBD. This review will focus on the use of fecal calprotectin to help diagnose, monitor, and determine treatment in IBD.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease
- The role of fecal calprotectin in pediatric disease
- Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
- Combination of leucine-rich alpha-2 glycoprotein and fecal markers detect Crohn’s disease activity confirmed by balloon-assisted enteroscopy
- Fecal calprotectin in daily practice for patients with inflammatory bowel disease: where do we stand in Korea?
